A. D. Colevas

Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck.

A. Nixon, S. Adak, R. Tishler, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.

S. Adak, R. Tishler, R. Fabian, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.

A. D. Colevas, A. Colevas, 1997, Oncology.

Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

S. Adak, R. Tishler, M. Posner, 2002, American journal of clinical oncology.

Docetaxel in head and neck cancer: a review.

M. Posner, A. D. Colevas, A. Colevas, 1998, American journal of clinical oncology.

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.

R. Tishler, P. Busse, E. Peters, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer.

Anurag K. Singh, J. Dancey, D. Citrin, 2010, International journal of radiation oncology, biology, physics.

1094TiP A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]

G. Daniels, D. Rischin, A. Haydon, 2021, Annals of Oncology.

A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck.

S. Adak, P. Amrein, M. Posner, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.

R. Tishler, P. Busse, E. Peters, 1999, International journal of radiation oncology, biology, physics.

155P BNT113 + pembrolizumab as first-line treatment in patients with unresectable recurrent/metastatic HNSCC: Preliminary safety data from AHEAD-MERIT

A. Atasoy, Ö. Türeci, R. Greil, 2022, Immuno-Oncology and Technology.